A population-based study of the white-coat blood pressure effect: Positive correlation with plasma cortisol

Clinical and Experimental Hypertension

Volumn 20, Issue 1, 1998, Pages 95-104

  Nyström, Fredrik ^a   Aardal, Elisabeth ^a   Öhman, K Peter ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ambulatory blood pressure; Cortisol; Neuropeptidt Y; Population study; Stress; White coat effect

Indexed keywords

HYDROCORTISONE; NEUROPEPTIDE Y;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; POPULATION RESEARCH; RADIOIMMUNOASSAY; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

EID: 0031909372     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969809053209     Document Type: Article

References (16)

1. Mancia G, Parati G, Pomidossi G, Grassi G, Cassadei RM. Alerting reactions and rise in blood pressure during measurement by physician and by nurse. Hypertension 1987;9:209-215.
2. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995;13:1377-1390.
3. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801.
4. Trenkwalder P, Plaschke M, Steffes-Tramer I, Lydtin H. "White coat" hypertension and alerting reaction in elderly and very elderly hypertensive patients. Blood Pressure 1993;2:262-271.
5. Gosse P, Promax H, Durandet P, Clementy J. "White coat" hypertension. No harm for the heart. Hypertension 1993;22(5):766-770.
6. al'Absi M, Lovallo WR, McKey BS, Pincomb GA. Borderline hypertensives produce exaggerated adrenocortical responses to mental stress. Psychosom Med 1994;56:245-250.
7. Henry JP, Stephens PM, Ely DL. Psychosocial hypertension and the defence and defeat reactions. J Hypertens 1986;4:687-697.
8. Henry JP. Biological basis of the stress response. Integr Physiol Behav Sci 1992;27:66-83.
9. Michel MC, Rascher W. Neuropeptide Y: a possible role in hypertension? J Hypertens 1995;13:385-395.
10. Lundberg JM, Rudehill A, Sollevi A, Theodorsson-Norheim E, Hamberger B. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci. Lett. 1986;63:96-100.
11. Heilig M, Ekman R. Chronic parenteral antidepressant treatment in rats: unaltered levels and processing of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH). Neurochem Int 1995;26:351-355.
12. Iversson LL, Salt PJ. Inhibition of catecholamine uptake 2 by steroids in the isolated rat heart. Br J Pharmacol 1970;40:528-530.
13. Kalsner S. Steroid potentiation of responses to sympathomimetic amines in aortic strips. Br J Pharmacol 1969;36:582-593.
14. Haig RM, Jones CT. Effect of glucocorticoids on alpha I-adrenergic receptor binding in rat vascular smooth muscle. J Mol Endocrinol 1990;5:41-48.
15. Matsamura K, Abe I, Fukuhara K, Fuji K, Ohya Y, Okamura K, Fujishima M. Modulation of circadian blood pressure rhythm of cortisol in patients with hypopituitarism. Clin Exp Hypertens 1994;16:55-66.
16. Zukowska-Grojec Z, Wahlestedt C. Origins and actions of neuropeptide Y in the cardiovascular system. In: Colmers WF, Wahlestedt C, ed. The Biology of Neuropeptide Y and Related Peptides. New Jersey: Humana Press, 1993: 315-388.